These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6573869)

  • 21. [Sensitivity of 7 mycobacterial species to new quinolones].
    Gevaudan MJ; Mallet MN; Gulian C; Terriou P; Lagier P; de Micco P
    Pathol Biol (Paris); 1988 May; 36(5):477-81. PubMed ID: 3136429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Renaudin H; Bébéar C
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):838-41. PubMed ID: 1964899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics.
    Niitu Y; Hasegawa S; Suetake T; Kubota H; Komatsu S; Horikawa M
    J Pediatr; 1970 Mar; 76(3):438-43. PubMed ID: 5413664
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antimycoplasmal effect of HI-78 (author's transl)].
    Ohta M; Ikebe A; Izumikawa K; Iwasaki H; Hara K
    Jpn J Antibiot; 1979 May; 32(5):638-41. PubMed ID: 459092
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro development of resistance to erythromycin, other macrolide antibiotics, and lincomycin in Mycoplasma pneumoniae.
    Nitu Y; Hasegawa S; Kubota H
    Antimicrob Agents Chemother; 1974 May; 5(5):513-9. PubMed ID: 4462466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of antibiotic sensitivity in 34 strains of large colony mycoplasma (author's transl)].
    Laborde M
    Pathol Biol (Paris); 1977 Oct; 25(8):541-6. PubMed ID: 339167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative in vitro activity of fleroxacin (RO 23-6240) against Ureaplasma urealyticum and Mycoplasma hominis.
    Krausse R; Ullmann U
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):67-9. PubMed ID: 3132382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility in vitro of gram-positive aerobe and anaerobe bacteria to ofloxacin.
    Debbia E; Mannelli S; Gianrossi G; Schito GC
    Drugs Exp Clin Res; 1987; 13(4):213-7. PubMed ID: 3304918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of five new quinolones against cultivable mycobacteria.
    Pattyn SR; Van Caekenberghe DL; Verhoeven JR
    Eur J Clin Microbiol; 1987 Oct; 6(5):572-3. PubMed ID: 3125049
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro and in vivo activities of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae.
    Gohara Y; Arai S; Akashi A; Kuwano K; Tseng CC; Matsubara S; Matumoto M; Furudera T
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1826-30. PubMed ID: 8239590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in-vitro activity of EN 272, a quinolone-7-carboxylic acid, in comparison with other quinolones.
    Neu HC
    J Antimicrob Chemother; 1985 Jul; 16(1):43-8. PubMed ID: 3862659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM; Baltch AL; Smith RP
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents.
    Kumada T; Neu HC
    J Antimicrob Chemother; 1985 Nov; 16(5):563-74. PubMed ID: 3865923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
    Periti P; Mazzei T; Nicoletti P
    Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
    Arpi M; Gahrn-Hansen B; Søgaard P; Bentzon MW
    Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.
    Saito A; Sawatari K; Fukuda Y; Nagasawa M; Koga H; Tomonaga A; Nakazato H; Fujita K; Shigeno Y; Suzuyama Y
    Antimicrob Agents Chemother; 1985 Jul; 28(1):15-20. PubMed ID: 3862361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of various antibiotics against Mycoplasma synoviae.
    Kleven SH; Anderson DP
    Avian Dis; 1971; 15(3):551-7. PubMed ID: 5099154
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibacterial activity of ofloxacin and its mode of action.
    Sato K; Inoue Y; Fujii T; Aoyama H; Mitsuhashi S
    Infection; 1986; 14 Suppl 4():S226-30. PubMed ID: 3028966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo antibacterial activities of E-4497, a new 3-amine-3-methyl-azetidinyl tricyclic fluoroquinolone.
    Gargallo-Viola D; Esteve M; Llovera S; Roca X; Guinea J
    Antimicrob Agents Chemother; 1991 Mar; 35(3):442-7. PubMed ID: 2039195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 1991 Mar; 35(3):587-9. PubMed ID: 1903913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.